A trail of complaints at pharmacy linked to meningitis deaths
Records show that inspectors knew about problems with an injectable steroid produced at the New England Compounding Center going back to 2002. The same tainted drug allegedly to blame for 23 meningitis deaths. Both documents, as well as testimony before a congressional committee, suggest a pattern of violations and modest penalties for the Framingham specialty pharmacy.
- As Retail Clinics Surge, Quality Metrics MIA
- Providers' Push to Consolidate Roils Payers
- Former NQF Co-Chair Linked to Conflicts of Interest in Journal Probe
- 6 Not-So-Good Reasons for Avoiding Population Health
- Medicare Cost, Quality Data Tools Weak, Says GAO
- No Employee Satisfaction, No Patient-Centered Culture
- RN Named Chief Patient Experience Officer
- Population Health Pays Off for NY Collaborative
- In PCMH, the 'P' is Not for 'Physician'
- How Simple Data Analytics is Driving Physician Incentives